Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RBKS |
| Upstream (Parents) |
|---|
| (<<) BDH1 → RBKS |
| (<<) CBS → RBKS |
| (<<) CYP4F2 → RBKS |
| (<<) GRHPR → RBKS |
| (<<) HSD11B1 → RBKS |
| (<<) HSD17B2 → RBKS |
| (<<) HYAL1 → RBKS |
| (<<) MT1P2 → RBKS |
| (<<) ORM1 → RBKS |
| (<<) RDH16 → RBKS |
| (<<) SAA4 → RBKS |
| (<<) SOD1 → RBKS |
| Downstream (Children) |
|---|
| RBKS → ACAT2 (>>) |
| RBKS → ACTB (>>) |
| RBKS → ACTG1 (>>) |
| RBKS → ANGPTL4 (>>) |
| RBKS → ARSA (>>) |
| RBKS → ATF4 (>>) |
| RBKS → CAT (>>) |
| RBKS → CDR2 (>>) |
| RBKS → CTSF (>>) |
| RBKS → CXCL2 (>>) |
| RBKS → CYP1A2 (>>) |
| RBKS → E2F3 (>>) |
| RBKS → ENC1 (>>) |
| RBKS → FNDC4 (>>) |
| RBKS → FZD3 (>>) |
| RBKS → FZD6 (>>) |
| RBKS → GALK1 (>>) |
| RBKS → GNA12 (>>) |
| RBKS → GNE (>>) |
| RBKS → GOT2 (>>) |
| RBKS → GSTZ1 (>>) |
| RBKS → HDAC2 (>>) |
| RBKS → HK1 (>>) |
| RBKS → LTA4H (>>) |
| RBKS → MAT2A (>>) |
| RBKS → MKNK2 (>>) |
| RBKS → MTMR6 (>>) |
| RBKS → MTSS1 (>>) |
| RBKS → MYC (>>) |
| RBKS → NUDT6 (>>) |
| RBKS → PDK2 (>>) |
| RBKS → PIK3C2B (>>) |
| RBKS → PKM2 (>>) |
| RBKS → RBP1 (>>) |
| RBKS → RHOA (>>) |
| RBKS → SET (>>) |
| RBKS → SMTN (>>) |
| RBKS → SOCS2 (>>) |
| RBKS → ST3GAL1 (>>) |
| RBKS → ST3GAL6 (>>) |
| RBKS → TSPAN3 (>>) |
